{"slug":"mechanisms","open_questions":[{"id":"open_question-3fc3ac93-718e-418f-a2ea-980d556b8247","title":"Are there safety concerns about enhancing synaptic adhesion in a system where over-connectivity could promote excitotoxicity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-be6c52ad-34f0-415a-b93e-e83e4bb65302","title":"Can NRXN-NLGN dysfunction be detected presymptomatically, enabling preventive intervention?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-21cbb04b-13de-4d42-a304-e3db25f755bd","title":"What is the optimal approach: enhancing existing complexes, replacing lost components, or building artificial bridges?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-b42f9d3b-4164-4089-bd54-858c58240f7e","title":"Cell-type specificity** — Can we achieve neuron-specific targeting?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-77868f83-fea2-487d-a259-6a39d315552d","title":"Can we develop therapies that selectively target pathological condensates?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-b27b4754-3e76-40b9-bef6-4c595b87ca5f","title":"What determines the transition from physiological to pathological phase separation?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-5688f748-770c-4e5b-9b97-0742cfab39b7","title":"Combination therapy:** Optimal partners?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-0c962161-64b7-4f98-8f0a-9b0e92aee8fe","title":"Therapeutic timing:** When is intervention most effective?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-b310c5e5-1b4b-4d28-8f38-f8425ba6b254","title":"Cellular context**: What determines microglial response?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-mechanisms-psp-oral-health-dental-manifestations-75bfde89","title":"Novel anticholinergics","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-092e8434-7b62-42b3-8653-70d647fa8b5a","title":"Strain identification**: How do strains determine phenotypes?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-6db5daa7-bec3-4ca5-b6f5-7c6a2d10a4e1","title":"Initiating events**: What triggers the first misfolding?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-23517227-1170-4b35-bb3a-b0d9c88e1cd5","title":"Are TLOs causative or consequential?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-3a3de2dd-0dac-41d8-a336-9c45f3457134","title":"Can TLOs be reversed?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-b82abc49-117c-4b78-9114-8d476d9e3820","title":"Can zombosomes be detected in cerebrospinal fluid or blood?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-307dba23-d713-4fb5-bc6d-8ac9ce55b2ec","title":"Is it specific to certain astrocyte subtypes?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-7c549cf0-114e-45a3-931d-fea948b7a789","title":"What cellular stress signals are required?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-0457b922-306f-4798-89fe-796afea48a8d","title":"Why are dopaminergic neurons particularly vulnerable?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-876395d6-8620-4aa9-b47d-5d20ea669d4d","title":"Temporal dynamics** — When does HS3ST2 upregulation occur relative to tau pathology?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-ccc7ad13-022a-4e84-b602-0e3bcef59981","title":"Therapeutic**: Optimal intervention point?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5}],"open_questions_total":20,"knowledge_gaps":[{"id":"gap-pubmed-20260410-105552-817f2752","title":"What are the detailed mechanisms by which different HCN isoforms modulate absence seizures?","domain":"epilepsy/seizure mechanisms","status":"open","importance_elo":1000.0},{"id":"gap-pubmed-20260410-105552-b13919f5","title":"How do HCN channels' opposite effects on cellular vs network excitability reconcile contradictory seizure outcomes?","domain":"epilepsy/seizure mechanisms","status":"open","importance_elo":1000.0},{"id":"gap-pubmed-20260410-181215-e5b58205","title":"What determines the specificity of TFEB-induced signaling endosomes for different cargo types?","domain":"cellular clearance mechanisms","status":"open","importance_elo":1000.0}],"gap_count":3,"landscape":null,"hypothesis_count":0,"personas":[{"id":"theorist","name":"Theorist","type":"debater","icon":"🧠","color":"#4fc3f7","debate_count":444},{"id":"skeptic","name":"Skeptic","type":"debater","icon":"⚠️","color":"#ffd54f","debate_count":443},{"id":"domain_expert","name":"Domain Expert","type":"debater","icon":"💊","color":"#81c784","debate_count":427},{"id":"synthesizer","name":"Synthesizer","type":"analyst","icon":"📊","color":"#ce93d8","debate_count":387},{"id":"clinical_trialist","name":"Clinical Trialist","type":"reviewer","icon":"📋","color":"#4dd0e1","debate_count":20},{"id":"computational_biologist","name":"Computational Biologist","type":"analyst","icon":"🧬","color":"#7986cb","debate_count":18},{"id":"ethicist","name":"Ethicist","type":"reviewer","icon":"⚖️","color":"#f48fb1","debate_count":8},{"id":"hongkui-zeng","name":"Hongkui Zeng","type":"debater","icon":"🧬","color":"#66bb6a","debate_count":7},{"id":"medicinal_chemist","name":"Medicinal Chemist","type":"builder","icon":"🧪","color":"#aed581","debate_count":7}]}